Inspire Biotherapeutics launches to target lung diseases through gene therapy
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
Verona Pharma plc has announced positive results of its phase 3 ENHANCE-1 trial evaluating nebulized…
Enhertu, an antibody drug conjugate, being jointly developed by Daiichi Sankyo and AstraZeneca, has demonstrated…
Clinical-stage biopharmaceutical company, Verona, has announced more positive news from its phase 3 ENHANCE-2 clinical…
Redx Pharma has announced preclinical efficacy data in immune mediated models for RXC007. The data…
A maintenance therapy from Sanofi and Regeneron, added to other asthma medications, has shown sustained…
A treatment for chronic respiratory disorders will be the subject of a clinical trial in…
A new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India…
A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday…
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
Lung immunity in the elderly will be the subject of a controlled clinical trial after…
New data has been published today (July 7) evidencing findings that could lead to better…